Company: BWAY
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001171843-25-002347
Chunk: 86

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: 20-F
Item: Item 5
Chunk 86
---
 Act. We also incur costs associated with corporate governance requirements,
including requirements under Section 404 and other provisions of the Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley Act), as well as rules
implemented by the SEC and The Nasdaq Global Market, and provisions of Israeli corporate law applicable to public companies, and the rules
of the TASE. These rules and regulations may increase our legal and financial compliance costs, introduce new costs such as investor relations,
increased insurance premiums and stock exchange listing fees, and may make some activities more time-consuming and costly. Our board members
and other personnel may need to devote a substantial amount of time to these initiatives. We are constantly evaluating and monitoring
developments with respect to these rules, and we cannot predict or estimate the amount of additional costs we may incur or the timing
of such costs.

Changes in the laws and regulations affecting public
companies will result in increased costs to us as we respond to their requirements. These laws and regulations could make it more difficult
or more costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to
accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these
requirements could also make it more difficult for us to attract and retain qualified persons to serve on our Board of Directors, our
board committees or as senior management. We cannot predict or estimate the amount or timing of additional costs we may incur in order
to comply with such requirements.

If
we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial
results or prevent fraud. As a result, shareholders could lose confidence in our financial and other public reporting, which would harm
our business and the trading price of the ADSs and Ordinary Shares.

Our management is required to assess the effectiveness
of our internal controls and procedures and disclose changes in these controls on an annual basis. Additionally, as we are no longer an
emerging growth company effective December 31, 2024 and are deemed to be an accelerated filer, pursuant to Section 404(b) of the Sarbanes-Oxley
Act we are required to include an auditor attestation on our internal control over financial reporting in the annual report.

Effective internal controls over financial reporting
are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed
to prevent fraud